Gilead 428-4025 - A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
September 30, 2020
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
September 30, 2020